U.S. market Closed. Opens in 7 hours 48 minutes

IRMD | IRadimed Corporation Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for IRMD we got that it has strong fundamentals where Valuation is considered to be overvalued, Profitability is stunning wealthy, Growth is exceptionally good and Health is confidently strong.

Valuation (34%)

Company Industry
P/E Ratio (TTM) 34.23 47.43
PEG Ratio (TTM) 8.10 -0.37
P/S Ratio (TTM) 9.19 6.17
P/B Ratio (TTM) 8.01 6.03
P/FCF Ratio (TTM) 49.09 41.68
Price to 5YR AVG Earnings Ratio 61.34 58.57
Price to 5YR AVG FCF Ratio 81.70 34.18

Profitability (90%)

Company Industry
ROA (TTM) 20.73% 5.30%
ROE (TTM) 24.71% 28.25%
Net Profit Margin (TTM) 26.83% 8.25%
ROIC 5YR AVG 64.07% 6.60%

Growth (93%)

4QTR AVG 3YR AVG 5YR AVG
EPS 5.27% 182.64% 123.09%
Revenue 2.69% 13.57% 18.24%
Net Income 5.11% 182.73% 123.96%
Cash Flow 47.69% 29.70% 22.48%

Health (81%)

Company Industry
Current Ratio (TTM) 9.87 2.90
Quick Ratio (TTM) 8.25 2.17
D/E Ratio (TTM) 0.00 0.61
Interest Coverage (TTM) 62.62 22.17
Piotroski F-Score 5 6
Altman Z-Score 40.59 7.62
LTL to 5YR AVG FCF 0.21 3.53
Shares Outstanding Growth 5YR AVG 3.25% 1.60%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙